Patent application

GeoVax Announces Issuance of Hepatitis B Vaccine Patent

Retrieved on: 
Wednesday, July 7, 2021
Medical specialties, Health, Clinical medicine, Infectious causes of cancer, Healthcare-associated infections, Viral diseases, Epidemiology, Virus, Zoonoses, Hepatitis, Patent application, Viral hepatitis

11,052,148, entitled Composition and Methods of Generating an Immune Response to Hepatitis B Virus.

Key Points: 
  • 11,052,148, entitled Composition and Methods of Generating an Immune Response to Hepatitis B Virus.
  • The abstract contained in the Companys patent application describes the invention as follows: The compositions and methods are described for generating an immune response to a hepatitis B virus.
  • The compositions and methods of the present invention are useful both prophylactically and therapeutically and may be used to prevent and/or treat an infection caused by hepatitis B virus.
  • We are pleased now to have been notified of the formal patent issuance.

CytoDyn Granted a Significant Patent by USPTO for Methods of Treating Coronavirus Infection with Leronlimab

Retrieved on: 
Tuesday, July 6, 2021
Intellectual property law, International Searching and Preliminary Examining Authorities, Patent offices, Patent application, United States Patent and Trademark Office, Patent, United States patent law, Outline of patents

11,045,546 by the U.S. Patent and Trademark Office (USPTO) for methods of treating coronavirus infection (the Patent).

Key Points: 
  • 11,045,546 by the U.S. Patent and Trademark Office (USPTO) for methods of treating coronavirus infection (the Patent).
  • The Patent is owned by CytoDyn and its term of protection is expected to extend at least until June 15, 2040.
  • The USPTO prioritized examination of CytoDyns patent application, resulting in the grant of this Patent under the USPTOs COVID-19 Prioritized Examination Pilot Program in just about one (1) year.
  • The Patent discloses methods of treating hyperinflammationa common complication of COVID-19 caused by SARS-CoV-2 coronavirus infection.

Nyxoah Announces Launch of Proposed Public Offering in the United States

Retrieved on: 
Friday, June 25, 2021
Corporate finance, Initial public offering, Financial economics, Finance, Money, Public offering, Patent application, SEC filings, United States securities law, Regulation S-K, Greenshoe

In connection with the Offering, Nyxoah intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares offered in the Offering on the same terms and conditions.

Key Points: 
  • In connection with the Offering, Nyxoah intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of ordinary shares offered in the Offering on the same terms and conditions.
  • An application has been made to list the ordinary shares on the NASDAQ Global Market under the same symbol.
  • This press release includes certain disclosures that contain forward-looking statements, including, without limitation, statements regarding the terms of the Offering.
  • No public offering will be made and no one has taken any action that would, or is intended to, permit a public offering in any country or jurisdiction, other than the United States, where any such action is required, including in Belgium.

Aquis Stock Exchange: Application for Admission

Retrieved on: 
Friday, June 25, 2021
R (L) v Comr of Police of the Metropolis, Security, Patent application, SEC filings

In respect of a fast-track applicant, the following information should also be included:

Key Points: 
  • In respect of a fast-track applicant, the following information should also be included:
    NAME OF MARKET ON WHICH THE APPLICANT'S SECURITIES ARE CURRENTLY TRADED:
    ARRANGEMENTS FOR THE SETTLEMENT OF TRANSACTIONS IN THE APPLICANT'S SECURITIES:
    DETAILS OF ANY LOCK-IN ARRANGEMENTS:
    DETAILS OF THE LEGAL OR REGULATORY REQUIREMENTS IN THE APPLICANT'S HOME COUNTRY REGARDING THE CONDUCT OF TAKEOVERS AND THE ACQUISITION OF SIGNIFICANT VOTING RIGHTS TO WHICH THE APPLICANT IS SUBJECT:
    In respect of an update to a prior application announcement, the date of the original announcement should also be disclosed as follows:
    UPDATE TO A PRIOR APPLICATION ANNOUNCEMENT RELEASED ON:
    Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.

GBT Filed a Patent for a Wireless Movement and Position Detection System

Retrieved on: 
Thursday, June 24, 2021
Intellectual property law, United States patent law, Patent offices, United States Patent and Trademark Office, United States trademark law, Patent and Trademark Office, Provisional application, Patent application

SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:GTCH ) ("GBT or the Company), filed a provisional patent (application number 63211573) with the U.S. Patent and Trademark Office (USPTO), for a real time movement and position detection method and system.

Key Points: 
  • SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- GBT Technologies Inc. ( OTC PINK:GTCH ) ("GBT or the Company), filed a provisional patent (application number 63211573) with the U.S. Patent and Trademark Office (USPTO), for a real time movement and position detection method and system.
  • An AI technology controls radio waves transmission and analyzes the reflected information to construct 2D and 3D images including real time movement.
  • The technology contemplates the inclusion of radio-based location system to enable accurate position of people and objects within the covered area.
  • GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology.

Emaginos Featured in Syndicated Broadcast Covering Recent Filing of a Provisional Patent for Game-Changing EdManage Analytics Platform

Intellectual property law, United States patent law, Patent application, Provisional application, United States Patent and Trademark Office, Patent

The audio press release covers the recent announcement regarding the filing of a provisional patent application with the United States Patent and Trademark Office ("USPTO") for its proprietary EdManage platform, an analytics platform that aggregates and analyzes all of a school districts data to deliver actionable information to users throughout the system.

Key Points: 
  • The audio press release covers the recent announcement regarding the filing of a provisional patent application with the United States Patent and Trademark Office ("USPTO") for its proprietary EdManage platform, an analytics platform that aggregates and analyzes all of a school districts data to deliver actionable information to users throughout the system.
  • If the parts are deliberately combined systematically into some new entity, then through synergy, the new entity emerges.
  • It could better be described as a heap of components trying to collaborate in delivering quality education to the students.
  • The EdManage analytics platform systematically aggregates these individual parts, morphing them into a new entity that is truly greater than the sum of its parts.

REPEAT - New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

Retrieved on: 
Monday, June 21, 2021
Intellectual property law, Medical specialties, Angiology, Amines, Ischemia, Stroke, United States Patent and Trademark Office, Patent application, N,N-Dimethyltryptamine, Blood

A provisional matter of composition patent application for AKO001 has been filed with the United States Patent and Trademark Office (USPTO) under application 63147343.

Key Points: 
  • A provisional matter of composition patent application for AKO001 has been filed with the United States Patent and Trademark Office (USPTO) under application 63147343.
  • Ischemia is a condition in which the blood vessels become blocked, and blood flow is stopped or reduced.
  • When blood flow is diminished to a body part, that body part also does not receive adequate oxygen.
  • Akomes specifically chosen plant bioactive and DMT are an ideal combination of compounds for mitigating the neurological damage caused by ischemic strokes.

New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

Retrieved on: 
Saturday, June 19, 2021
Intellectual property law, Medical specialties, Angiology, Amines, Ischemia, Stroke, United States Patent and Trademark Office, Patent application, N,N-Dimethyltryptamine, Blood

A provisional matter of composition patent application for AKO001 has been filed with the United States Patent and Trademark Office (USPTO) under application 63147343.

Key Points: 
  • A provisional matter of composition patent application for AKO001 has been filed with the United States Patent and Trademark Office (USPTO) under application 63147343.
  • Ischemia is a condition in which the blood vessels become blocked, and blood flow is stopped or reduced.
  • When blood flow is diminished to a body part, that body part also does not receive adequate oxygen.
  • Akomes specifically chosen plant bioactive and DMT are an ideal combination of compounds for mitigating the neurological damage caused by ischemic strokes.

FuelPositive Featured in Syndicated Broadcast Covering Recent Filing of Patent Application for Clean Hydrogen and Ammonia Technology

Retrieved on: 
Friday, June 18, 2021
Intellectual property law, Chemistry, Chemical substances, United States patent law, Industrial gases, Emerging technologies, Ammonia, Nitrogen cycle, Provisional application, Patent application, Patent, United States Patent and Trademark Office

The audio press release covers the recent announcement regarding the filing of a patent application for the Companys Modular Transportable Clean Hydrogen-Ammonia Maker with the United States Patent and Trademark Office (U.S. provisional patent application number: 63197884).

Key Points: 
  • The audio press release covers the recent announcement regarding the filing of a patent application for the Companys Modular Transportable Clean Hydrogen-Ammonia Maker with the United States Patent and Trademark Office (U.S. provisional patent application number: 63197884).
  • This milestone for FuelPositive further reinforces the potential for the global implementation of our technology, and we are working rapidly toward commercialization, with Phase 2 commercial demonstration systems well on their way to being realized.
  • FuelPositive is a Canadian-based growth stage company committed to providing commercially viable and sustainable energy solutions, including clean ammonia (NH3), for use across a broad spectrum of industries, systems and applications.
  • Forward-looking statements are provided for the purpose of providing information about managements expectations and plans relating to the future.

Aquis Stock Exchange: Application for admission

Retrieved on: 
Thursday, June 17, 2021
R (L) v Comr of Police of the Metropolis, Security, Patent application, SEC filings

In respect of a fast-track applicant, the following information should also be included:

Key Points: 
  • In respect of a fast-track applicant, the following information should also be included:
    NAME OF MARKET ON WHICH THE APPLICANT'S SECURITIES ARE CURRENTLY TRADED:
    ARRANGEMENTS FOR THE SETTLEMENT OF TRANSACTIONS IN THE APPLICANT'S SECURITIES:
    DETAILS OF ANY LOCK-IN ARRANGEMENTS:
    DETAILS OF THE LEGAL OR REGULATORY REQUIREMENTS IN THE APPLICANT'S HOME COUNTRY REGARDING THE CONDUCT OF TAKEOVERS AND THE ACQUISITION OF SIGNIFICANT VOTING RIGHTS TO WHICH THE APPLICANT IS SUBJECT:
    In respect of an update to a prior application announcement, the date of the original announcement should also be disclosed as follows:
    UPDATE TO A PRIOR APPLICATION ANNOUNCEMENT RELEASED ON:
    Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.